Detalles de la búsqueda
1.
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
Oncologist
; 29(5): e690-e698, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377176
2.
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(9): 989-1001, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37591293
3.
Neoadjuvant or Perioperative Approach in Lung Cancer.
N Engl J Med
; 390(19): 1816-1818, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749039
4.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Future Oncol
; 18(23): 2593-2604, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722877
5.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499874
6.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285097
7.
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Cancer Immunol Immunother
; 70(9): 2429-2438, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797567
8.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
9.
Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non-small Cell Lung Cancer.
Curr Oncol Rep
; 22(5): 41, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32296957
10.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Lancet Oncol
; 19(4): 521-536, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545095
11.
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Tumour Biol
; 40(11): 1010428318815047, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30486741
12.
Treatment of lung large cell neuroendocrine carcinoma.
Tumour Biol
; 37(6): 7047-57, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26943800
13.
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.
Tumour Biol
; 37(10): 12991-13003, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27460087
14.
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Lancet Oncol
; 14(10): 981-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883922
15.
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
J Exp Clin Cancer Res
; 43(1): 6, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38163906
16.
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Clin Cancer Res
; 30(4): 824-835, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801329
17.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; : 3008916241229287, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045
18.
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
J Clin Oncol
; 42(2): 192-204, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38039427
19.
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
Cancer Med
; 13(9): e7159, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741546
20.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Eur J Cancer
; 195: 113404, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37948842